期刊
PHARMACEUTICS
卷 14, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14071423
关键词
ROS; RNS; hispolon; inflammation; immunomodulation; macrophage; mouse splenocyte; proliferation
资金
- Korea Institute of Toxicology, Korea [NTIS: 1711159828, KK-2212-02]
Hispolon is a versatile drug with anti-cancer, anti-inflammatory, antioxidant, and antidiabetic properties, which can be extracted from the oriental medicinal mushroom Phellinus linteus. Research indicates that Hispolon has immunomodulatory effects on macrophages and lymphocytes, inhibiting oxidative stress, reducing inflammatory responses, and decreasing lymphocyte proliferation. It may have therapeutic potential for immune-mediated inflammatory diseases.
Hispolon is a potent anticancer, anti-inflammatory, antioxidant, and antidiabetic agent isolated from Phellinus linteus, an oriental medicinal mushroom. However, the immunomodulatory mechanisms by which hispolon affects macrophages and lymphocytes remain poorly characterized. We investigated the immunomodulatory effects of hispolon on oxidative stress, inflammatory responses, and lymphocyte proliferation using lipopolysaccharide (LPS)-treated RAW264.7 macrophages or mitogen/alloantigen-treated mouse splenocytes. Hispolon inhibited LPS-induced reactive oxygen and nitrogen species (ROS/RNS) generation and decreased total sulfhydryl (SH) levels in a cell-free system and RAW264.7 cells. Hispolon exerted significant anti-inflammatory effects by inhibiting production of the proinflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) and activation of nuclear factor kappa B (NF-kappa B) and signal transducer and activator of transcription 3 (STAT3) in LPS-treated RAW264.7 cells. Hispolon also modulated NF-kappa B and STAT3 activation by suppressing the NF-kappa B p65 interaction with phospho-I kappa B alpha and the STAT3 interaction with JAK1, as determined via coimmunoprecipitation analysis. Additionally, hispolon significantly decreased lymphocyte proliferation, T cell responses and T helper type 1 (Th1)/type 2 (Th2) cytokines production in mitogen/alloantigen-treated splenocytes. We conclude that hispolon exerts immunomodulatory effects on LPS-treated macrophages or mitogen/alloantigen-treated splenocytes through antioxidant, anti-inflammatory, and antiproliferative activities. Thus, hispolon may be a therapeutic agent for treating immune-mediated inflammatory diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据